Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct;11(5):704-709.
doi: 10.1093/ckj/sfy007. Epub 2018 Mar 9.

Multi-intervention management of calcific uremic arteriolopathy in 24 patients

Claire Harris  1 , Mercedeh Kiaii  1 , Wynnie Lau  2 , Myriam Farah  1
Affiliations

Multi-intervention management of calcific uremic arteriolopathy in 24 patients

Claire Harris et al. Clin Kidney J. 2018 Oct.

Abstract

Background: Calcific uremic arteriolopathy (CUA), also known as calciphylaxis, is a rare but life-threatening condition predominately occurring in patients with end-stage renal disease on dialysis. In the absence of randomized clinical trials to guide management, clinicians must rely on observational data. We have previously reported the outcomes of our multi-intervention management in seven patients and now present a larger series of patients with extended follow-up.

Methods: We performed a retrospective analysis of all patients diagnosed with CUA at a single academic center between 2008 and 2017. We identified 24 patients including 13 hemodialysis, 8 peritoneal dialysis and 3 predialysis Stage 5 chronic kidney disease patients.

Results: Mean age at diagnosis was 60.5 years (range 35-83) and mean follow-up 30.5 months (range <1-99). Patients were predominately female (71%) and Caucasian (83%) with diabetes mellitus diagnosed in 16 of 24 patients. Fifteen of 24 patients had ulcerating lesions suggestive of advanced disease and 20 of 24 had extensive involvement (bilateral disease or lesion size >5 cm). Treatment consisted of intensive hemodialysis (>20 h per week), sodium thiosulfate, wound care, analgesics and discontinuation of trigger medications including warfarin. Hyperbaric oxygen, cinacalcet, bisphosphonates and vitamin K were used in some cases. Overall 1 year mortality was 41% (9/22) and overall mortality at the end of follow-up was 64% (14/24). Cause of death was felt to be attributable to CUA in only four cases (16.7%). Complete or partial resolution of lesions occurred in 17 of 24 patients. One patient had recurrence of CUA 20 months after initial diagnosis.

Conclusions: Although mortality remains high in this group, direct CUA-attributable mortality is lower than historic reports. We conclude that a multi-intervention approach can be successful in treating a group of patients with severe CUA lesions.

Keywords: ESRD; calcific uremic arteriolopathy; calciphylaxis; sodium thiosulfate; vitamin K.

PubMed Disclaimer

References

    1. Wolff K, Johnson R.. Fitzpatrick’s Color Atlas and Synopsis of Clinical Dermatology, 6th edn. New York, NY: McGraw-Hill Professional, 2009
    1. Nigwekar SU, Kroshinsky D, Nazarian RM. et al. Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis 2015; 66: 133–146 - PMC - PubMed
    1. Fine A, Zacharias J.. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int 2002; 61: 2210–2217 - PubMed
    1. Angelis M, Wong LL, Myers SA. et al. Calciphylaxis in patients on hemodialysis: a prevalence study. Surgery 1997; 122: 1083. - PubMed
    1. Brandenburg VM, Kramann R, Rothe H.. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry. Nephrol Dial Transplant 2017; 32: 126–132 - PubMed